Ergoteles’s ChemoCentryx, Inc. CCXI Stock Holding History

Ergoteles’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-373,020	Closed	-$19.3M	–	2163
2022 Q3	$19.3M	Buy	+373,020	New	+$15.4M	0.68%	17
2021 Q4	–	Sell	-69,920	Closed	-$1.2M	–	1737
2021 Q3	$1.2M	Buy	+69,920	New	+$1.09M	0.04%	341
2021 Q2	–	Sell	-15,600	Closed	-$799K	–	1752
2021 Q1	$799K	Buy	+15,600	New	+$939K	0.02%	410

Other funds holding CCXI

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Ergoteles's CCXI Position: Q4 2022 in Review

Ergoteles sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 373,020 shares — an estimated $19.3M sold.

Ergoteles first reported a position in CCXI in Q1 2021 and held it in 3 quarters. The position peaked at $19.3M in Q3 2022. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

Ergoteles reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
Ergoteles sold 373,020 ChemoCentryx, Inc. shares in Q4 2022, an estimated $19.3M.
Ergoteles first reported a position in ChemoCentryx, Inc. in Q1 2021 and held it in 3 quarters.
Ergoteles's ChemoCentryx, Inc. position peaked at $19.3M in Q3 2022.
1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on Ergoteles's 13F filing for Q4 2022, filed 14 Feb 2023.